Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer

Completed · Phase 1

Conditions studied: Non Small Cell Lung Cancer

In brief

The purpose of this study is to determine whether the investigational study drug everolimus may be used to increase the effectiveness of chemotherapy treatment for patients with advanced lung cancer.

Key facts

Study ID

NCT01700400

Run by

Cancer Research and Biostatistics Clinical Trials Consortium

People needed

13

Starts

2012-09-01

Expected to finish

2014-10-01

Last updated by the study team

2014-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Arizona Cancer Center — Tuscon, Arizona, United States
• University of Kentucky Markey Cancer Center — Lexington, Kentucky, United States
• Providence Cancer Center — Portland, Oregon, United States
• Cancer Research And Biostatistics Clinical Trials Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.